China conditionally approved the registration application of a self-developed recombinant protein subunit vaccine against COVID-19, the National Medical Products Administration said Wednesday, according to Xinhua. The vaccine, developed by Anhui Zhifei Longcom Biopharmaceutical Co., Ltd., was allowed
© Provided by Xinhua BEIJING, March 2 (Xinhua) China conditionally approved the registration application of a self-developed recombinant protein sub
China conditionally approved the registration application of a self-developed recombinant protein subunit vaccine against COVID-19, the National Medical Products Administration said Wednesday.
© Provided by Xinhua BEIJING, March 2 (Xinhua) China conditionally approved the registration application of a self-developed recombinant protein sub